Genesee Capital Advisors’s Coca-Cola Europacific Partners CCEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Sell
10,239
-82
-0.8% -$8.68K 0.33% 65
2026
Q2
$1.03M Buy
10,321
+102
+1% +$9.7K 0.33% 68
2026
Q1
$927K Sell
10,219
-1,038
-9% -$100K 0.39% 64
2025
Q4
$1.02M Buy
11,257
+137
+1% +$12.4K 0.41% 60
2025
Q3
$1.01M Sell
11,120
-3
-0% -$278 0.44% 57
2025
Q2
$1.03M Buy
11,123
+189
+2% +$16.9K 0.46% 57
2025
Q1
$952K Buy
10,934
+931
+9% +$75.9K 0.48% 48
2024
Q4
$768K Sell
10,003
-99
-1% -$7.65K 0.36% 62
2024
Q3
$796K Sell
10,102
-1,789
-15% -$137K 0.38% 60
2024
Q2
$867K Buy
11,891
+217
+2% +$15.6K 0.43% 53
2024
Q1
$817K Buy
+11,674
New +$802K 0.45% 51

Other funds holding CCEP

Genesee Capital Advisors's CCEP Position: Q3 2026 in Review

Genesee Capital Advisors reduced its Coca-Cola Europacific Partners (CCEP) stake by 0.79% in Q3 2026, selling an estimated $8.68K and leaving 10,239 shares worth $1.04M. The position accounts for 0.33% of the portfolio, ranked #65.

Genesee Capital Advisors first reported a position in CCEP in Q1 2024 and has held it in 11 quarters since. 573 funds tracked by Wall St. Rank hold CCEP as of Q3 2026.

  • Genesee Capital Advisors held 10,239 shares of Coca-Cola Europacific Partners worth $1.04M as of Q3 2026.
  • Genesee Capital Advisors sold 82 Coca-Cola Europacific Partners shares in Q3 2026, an estimated $8.68K.
  • Coca-Cola Europacific Partners made up 0.33% of Genesee Capital Advisors's portfolio in Q3 2026, its #65 holding.
  • Genesee Capital Advisors first reported a position in Coca-Cola Europacific Partners in Q1 2024 and has held it in 11 quarters since.
  • 573 funds tracked by Wall St. Rank held Coca-Cola Europacific Partners as of Q3 2026.

Based on Genesee Capital Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.